Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 943.7M | 705.1M | 787.6M | 587.4M | 810.5M | 729.3M | 1.12B | 599.7M | 514.2M | 372.8M | 283.7M | 214.2M | 147.3M | 102.0M | 99.1M | 108.5M | 121.6M | 107.2M |
| Gross Profit | 927.8M | 693.9M | 778.5M | 573.3M | 799.6M | 717.3M | 1.12B | 597.9M | 514.2M | 372.8M | — | — | — | — | — | — | — | — |
| Profitability | ||||||||||||||||||
| Operating Income | -381.7M | -475.1M | -353.7M | -410.2M | -30.2M | -172.1M | 365.9M | -61.4M | 31.0M | -20.2M | -75.8M | -47.7M | -51.7M | -68.9M | -71.1M | -48.4M | -27.5M | -13.1M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -381.4M | -453.9M | -366.3M | -269.7M | -28.6M | -444.3M | 278.1M | 273.7M | 346,000 | -60.4M | -88.3M | -39.0M | -60.6M | — | — | -61.3M | 155.1M | -18.2M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 160M | 150M | 143M | 142M | 141M | 140M | 153M | 134M | 126M | 121M | 120M | 118M | 111M | 101M | 100M | 99M | 98M | 95M |
Ionis Pharmaceuticals, Inc. Income Statement — FAQ
Ionis Pharmaceuticals, Inc. (IONS) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IONS's income statement history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.